Onconova Therapeutics, Inc.-Product Pipeline Review-2015

Onconova Therapeutics, Inc.-Product Pipeline Review-2015

  • Products Id :- GMDHC07411CDB
  • |
  • Pages: 50
  • |
  • |
  • |
  Request for Sample Report
  Request A Quote

Executive Summary

Onconova Therapeutics, Inc.-Product Pipeline Review-2015


Global Markets Direct's, 'Onconova Therapeutics, Inc.-Product Pipeline Review-2015', provides an overview of the Onconova Therapeutics, Inc.'s pharmaceutical research and development focus.

This report provides comprehensive information on the current therapeutic developmental pipeline of Onconova Therapeutics, Inc.'s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.

Global Markets Direct's report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.


The report provides brief overview of Onconova Therapeutics, Inc. including business description, key information and facts, and its locations and subsidiaries

The report reviews current pipeline of Onconova Therapeutics, Inc.'s human therapeutic division and enlists all their major and minor projects

The report features product description and descriptive mechanism of action for key pipeline products along with the product's developmental history and major milestones

Special feature on out-licensed and partnered product portfolio

The report summarizes all the dormant and discontinued pipeline projects

Latest company statement

Latest news and deals relating to the Onconova Therapeutics, Inc.'s pipeline products

Reasons To Buy

Evaluate Onconova Therapeutics, Inc.'s strategic position with total access to detailed information on its product pipeline

Assess the growth potential of Onconova Therapeutics, Inc. in its therapy areas of focus

Identify new drug targets and therapeutic classes in the Onconova Therapeutics, Inc.'s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas

Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps

Develop strategic initiatives by understanding the focus areas of Onconova Therapeutics, Inc. and exploit collaboration and partnership opportunities

Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage

Plan mergers and acquisitions effectively by identifying the most promising pipeline of Onconova Therapeutics, Inc.

Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope

Explore the dormant and discontinued projects of Onconova Therapeutics, Inc. and identify potential opportunities in those areas

Avoid Intellectual Property Rights related issues

Read More

Contact Us:
Ken Research
Ankur Gupta, Head Marketing & Communications


Table of Contents

Table of Contents 2

List of Tables 4

List of Figures 4

Onconova Therapeutics, Inc. Snapshot 5

Onconova Therapeutics, Inc. Overview 5

Key Information 5

Key Facts 5

Onconova Therapeutics, Inc.-Research and Development Overview 6

Key Therapeutic Areas 6

Onconova Therapeutics, Inc.-Pipeline Review 9

Pipeline Products by Stage of Development 9

Pipeline Products-Monotherapy 10

Onconova Therapeutics, Inc.-Pipeline Products Glance 11

Onconova Therapeutics, Inc.-Late Stage Pipeline Products 11

Phase III Products/Combination Treatment Modalities 11

Onconova Therapeutics, Inc.-Clinical Stage Pipeline Products 12

Phase II Products/Combination Treatment Modalities 12

Phase I Products/Combination Treatment Modalities 13

Onconova Therapeutics, Inc.-Early Stage Pipeline Products 14

Preclinical Products/Combination Treatment Modalities 14

Discovery Products/Combination Treatment Modalities 15

Onconova Therapeutics, Inc.-Drug Profiles 16

rigosertib sodium 16

Product Description 16

Mechanism of Action 16

R&D Progress 16

briciclib sodium 21

Product Description 21

Mechanism of Action 21

R&D Progress 21

recilisib sodium 22

Product Description 22

Mechanism of Action 22

R&D Progress 22

ON-015640 24

Product Description 24

Mechanism of Action 24

R&D Progress 24

ON-108600 25

Product Description 25

Mechanism of Action 25

R&D Progress 25

ON-1231320 26

Product Description 26

Mechanism of Action 26

R&D Progress 26

ON-123300 28

Product Description 28

Mechanism of Action 28

R&D Progress 28

ON-146040 29

Product Description 29

Mechanism of Action 29

R&D Progress 29

ON-24 Series 30

Product Description 30

Mechanism of Action 30

R&D Progress 30

ON-24160 31

Product Description 31

Mechanism of Action 31

R&D Progress 31

ON-108110 32

Product Description 32

Mechanism of Action 32

R&D Progress 32

ON-128060 33

Product Description 33

Mechanism of Action 33

R&D Progress 33

Onconova Therapeutics, Inc.-Pipeline Analysis 34

Onconova Therapeutics, Inc.-Pipeline Products by Target 34

Onconova Therapeutics, Inc.-Pipeline Products by Route of Administration 36

Onconova Therapeutics, Inc.-Pipeline Products by Molecule Type 37

Onconova Therapeutics, Inc.-Pipeline Products by Mechanism of Action 38

Onconova Therapeutics, Inc.-Recent Pipeline Updates 39

Onconova Therapeutics, Inc.-Dormant Projects 46

Onconova Therapeutics, Inc.-Discontinued Pipeline Products 47

Discontinued Pipeline Product Profiles 47

rigosertib sodium 47

Onconova Therapeutics, Inc.-Locations And Subsidiaries 48

Head Office 48

Other Locations & Subsidiaries 48

Appendix 49

Methodology 49

Coverage 49

Secondary Research 49

Primary Research 49

Expert Panel Validation 49

Contact Us 49

Disclaimer 50

List of Tables

Onconova Therapeutics, Inc., Key Information 5

Onconova Therapeutics, Inc., Key Facts 5

Onconova Therapeutics, Inc.-Pipeline by Indication, 2015 7

Onconova Therapeutics, Inc.-Pipeline by Stage of Development, 2015 9

Onconova Therapeutics, Inc.-Monotherapy Products in Pipeline, 2015 10

Onconova Therapeutics, Inc.-Phase III, 2015 11

Onconova Therapeutics, Inc.-Phase II, 2015 12

Onconova Therapeutics, Inc.-Phase I, 2015 13

Onconova Therapeutics, Inc.-Preclinical, 2015 14

Onconova Therapeutics, Inc.-Discovery, 2015 15

Onconova Therapeutics, Inc.-Pipeline by Target, 2015 35

Onconova Therapeutics, Inc.-Pipeline by Route of Administration, 2015 36

Onconova Therapeutics, Inc.-Pipeline by Molecule Type, 2015 37

Onconova Therapeutics, Inc.-Pipeline Products by Mechanism of Action, 2015 38

Onconova Therapeutics, Inc.-Recent Pipeline Updates, 2015 39

Onconova Therapeutics, Inc.-Dormant Developmental Projects,2015 46

Onconova Therapeutics, Inc.-Discontinued Pipeline Products, 2015 47

Onconova Therapeutics, Inc., Other Locations 48

List of Figures

Onconova Therapeutics, Inc.-Pipeline by Top 10 Indication, 2015 7

Onconova Therapeutics, Inc.-Pipeline by Stage of Development, 2015 9

Onconova Therapeutics, Inc.-Monotherapy Products in Pipeline, 2015 10

Onconova Therapeutics, Inc.-Pipeline by Top 10 Target, 2015 34

Onconova Therapeutics, Inc.-Pipeline by Top 10 Route of Administration, 2015 36

Onconova Therapeutics, Inc.-Pipeline by Top 10 Molecule Type, 2015 37

Onconova Therapeutics, Inc.-Pipeline Products by Top 10 Mechanism of Action, 2015 38

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License:
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to query [@] kenresearch.com

Current R&D Portfolio of Onconova Therapeutics, Inc.; Onconova Therapeutics, Inc. - Key Therapeutics; Onconova Therapeutics, Inc. - Pipeline Overview and Promising Molecules; Onconova Therapeutics, Inc. - News; Onconova Therapeutics, Inc. - Latest Updates; Onconova Therapeutics, Inc. - Pipeline; Onconova Therapeutics, Inc. - Discontinued/Dormant Projects

select a license

Single User License
USD 1500 INR 97410
Site License
USD 3000 INR 194820
Corporate User License
USD 4500 INR 292230



The report sent to us was on the point, and its information was quite extensive, well structured, and well researched. More importantly what we valued was your response time and professionalism. As a leading global consulting firm, our clients expect high quality deliverables in short periods of time, so a reliable research partner is essential. For the price that you have charged the quality of your services were exceptional. We look forward to continue our relationship with your team on future engagements....

This is with regards to your report on India PVC pipes and fitting market outlook industry outlook to 2019. This is a very well written report and accept my compliments on the same.... ...

I am pleased to see the very useful and productive information in the report..Very well structured great presentation reflect professionalism in your research studies....

While we still are studying and analysing your reports about Vietnam & Thailand, we would like to convey to your research team that they have done a very good job in compiling so much of information together. We hope to see more of such well researched reports. All the best & keep it up. ...

We would like to appreciate Ken Research for their great efforts and wonderful support in providing the Market Intelligence Report for ITPC. The information, statistics and research are well understandable and very clear to the point. We are happy with Ken research for their good client service, on-time delivery of the report and as said the report itself. Thank you Ken research for bringing the valuable output for us. We would be looking forward to have more research with you in the near future. Wish you a success in your business!...

Related Products in vertical
Ken Research Pvt. Ltd. Unit 14, Tower B3, Spaze I Tech Business Park, Sohna Road, sector 49
     Gurgaon, Haryana - 122001, India


Company Brochure

Engage with Us

query [@] kenresearch.com